ATP5IF1 and acute myeloid leukemia: To test this hypothesis, we examined whether non-AML cells (HCT116), which do not exhibit matrix ATP hydrolysis, would show more robust ATP5IF1 overexpression when infected with the same lentiviral vector used in our AML models.